Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis

Overview of attention for article published in European Urology Oncology, March 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 1,050)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 11 news outlets
twitter: 51 X users

guideline: 2 clinical guideline sources

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 61 X posts from 51 X users, with an upper bound of 137,041 followers.

RT @EurUrolOncol: @EurUrolOncol Current Highlight: Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–musc…

@EurUrolOncol Current Highlight: Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–muscle-invasive #BladderCancer After Bacillus Calmette-Guerin Therapy https://t.co/hhk8zbWn3v @UroDocAsh https://t.co/cPCqdBtIC4

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 57 additional X posts.